This Foley Executive Briefing Series program examined the common sources of litigation for life sciences companies as well as methods for mitigating exposure when these issues arise.
The program explored the potential litigation challenges that arise in light of intellectual property (IP) issues, IP ownership challenges arising out of collaborations or movements of personnel, and conflicts of interest in research, and addressed their implications for life sciences companies.
Questions that were discussed include:
- What are the key exposure areas for life sciences companies?
- What is involved in litigating these issues?
- What types of relief may be sought?
- What does litigation cost?
- Are there alternatives to litigation?
This interactive program was moderated by Foley Partners J. Mark Waxman and Thomas I. Elkind.
People
Related Insights
March 11, 2026
Tariff & International Trade Resource
What Every Multinational Should Know About…Managing the Aftermath of the Supreme Court’s IEEPA Tariff Decision (Part III)
The importer of record is the entity that initially pays all tariffs and thus is the entity that would receive any IEEPA tariff refunds. Nonetheless, behind the scenes there often are a variety of mechanisms importers of record may have used to handle the often unexpected tariffs, including pushing back on suppliers for price concessions, using surcharges to pass along tariffs, or generally increasing price. In many cases, other parties may be looking to share any potential refunds.
March 11, 2026
Manufacturing Industry Advisor
How Supply Chain Mapping Strengthens Supply Chain Integrity
The last six years have brought vast changes in the U.S. regulatory landscape (e.g., tariff volatility, new supply chain integrity rules), unprecedented raw material shortages, and a global pandemic, just to list a few high-profile examples. This has led to unprecedented supply chain unpredictability.
March 10, 2026
The Path & The Practice
Episode 133: Casey Knapp, Partner
This episode of The Path & The Practice features a conversation with Marshall Keen, a summer associate in Foley’s Dallas office.